2. Academic Validation
  3. COVID-19: A Brief Overview of the Discovery Clinical Trial

COVID-19: A Brief Overview of the Discovery Clinical Trial

  • Pharmaceuticals (Basel). 2020 Apr 10;13(4):65. doi: 10.3390/ph13040065.
Jean Jacques Vanden Eynde 1
Affiliations

Affiliation

  • 1 Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium.
PMID: 32290348 DOI: 10.3390/ph13040065
Abstract

The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.

Keywords

COVID-19; SARS-CoV-2; chloroquine; hydroxychloroquine; lopinavir/ritonavir; remdesivir; repurposing.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z